Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen

NCT00417209 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Larotaxel (XRP9881)
DRUG: 5-Fluorouracil
DRUG: Capecitabine

Sponsor

Sanofi